Literature DB >> 12183585

A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis.

T Atkins1, R G Prior, K Mack, P Russell, M Nelson, P C F Oyston, G Dougan, R W Titball.   

Abstract

Using a transposon mutagenesis approach, we have identified a mutant of Burkholderia pseudomallei that is auxotrophic for branched chain amino acids. The transposon was shown to have interrupted the ilvI gene encoding the large subunit of the acetolactate synthase enzyme. Compared to the wild type, this mutant was significantly attenuated in a murine model of disease. Mice inoculated intraperitoneally with the auxotrophic mutant, 35 days prior to challenge, were protected against a challenge dose of 6,000 median lethal doses of wild-type B. pseudomallei.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183585      PMCID: PMC128252          DOI: 10.1128/IAI.70.9.5290-5294.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection.

Authors:  D M Klinman; J Conover; C Coban
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  Immunization with an induced avirulent auxotrophic mutant of Pseudomonas pseudomallei.

Authors:  H B LEVINE; R L MAURER
Journal:  J Immunol       Date:  1958-11       Impact factor: 5.422

3.  Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates.

Authors:  P J Brett; D E Woods
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 4.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

Authors:  S F Altschul; T L Madden; A A Schäffer; J Zhang; Z Zhang; W Miller; D J Lipman
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

5.  The efficacy of ciprofloxacin and doxycycline against experimental tularaemia.

Authors:  P Russell; S M Eley; M J Fulop; D L Bell; R W Titball
Journal:  J Antimicrob Chemother       Date:  1998-04       Impact factor: 5.790

6.  Leucine auxotrophy restricts growth of Mycobacterium bovis BCG in macrophages.

Authors:  F C Bange; A M Brown; W R Jacobs
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

7.  Salmonella typhimurium aroB mutants are attentuated in BALB/c mice.

Authors:  A Günel-Ozcan; K A Brown; A G Allen; D J Maskell
Journal:  Microb Pathog       Date:  1997-11       Impact factor: 3.738

Review 8.  Pathogenesis of and immunity to melioidosis.

Authors:  P J Brett; D E Woods
Journal:  Acta Trop       Date:  2000-02-05       Impact factor: 3.112

9.  Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species.

Authors:  P J Brett; D DeShazer; D E Woods
Journal:  Int J Syst Bacteriol       Date:  1998-01

10.  Lipopolysaccharide from nonvirulent Ara+ Burkholderia pseudomallei isolates is immunologically indistinguishable from lipopolysaccharide from virulent Ara- clinical isolates.

Authors:  N Anuntagool; P Intachote; V Wuthiekanun; N J White; S Sirisinha
Journal:  Clin Diagn Lab Immunol       Date:  1998-03
View more
  58 in total

1.  Role of RelA and SpoT in Burkholderia pseudomallei virulence and immunity.

Authors:  Claudia M Müller; Laura Conejero; Natasha Spink; Matthew E Wand; Gregory J Bancroft; Richard W Titball
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

2.  Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection.

Authors:  Gareth D Healey; Stephen J Elvin; Margaret Morton; E Diane Williamson
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  CD4+ T-cell immunity to the Burkholderia pseudomallei ABC transporter LolC in melioidosis.

Authors:  Karen K Chu; Patcharaporn Tippayawat; Nicola J Walker; Sarah V Harding; Helen S Atkins; Bernard Maillere; Gregory J Bancroft; Ganjana Lertmemongkolchai; Daniel M Altmann
Journal:  Eur J Immunol       Date:  2010-12-03       Impact factor: 5.532

4.  Fate of a Burkholderia pseudomallei lipopolysaccharide mutant in the mouse macrophage cell line RAW 264.7: possible role for the O-antigenic polysaccharide moiety of lipopolysaccharide in internalization and intracellular survival.

Authors:  S Arjcharoen; C Wikraiphat; M Pudla; K Limposuwan; D E Woods; S Sirisinha; P Utaisincharoen
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

5.  Antibodies against In Vivo-Expressed Antigens Are Sufficient To Protect against Lethal Aerosol Infection with Burkholderia mallei and Burkholderia pseudomallei.

Authors:  Shawn M Zimmerman; Jeremy S Dyke; Tomislav P Jelesijevic; Frank Michel; Eric R Lafontaine; Robert J Hogan
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

Review 6.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

7.  Global map of growth-regulated gene expression in Burkholderia pseudomallei, the causative agent of melioidosis.

Authors:  Fiona Rodrigues; Mitali Sarkar-Tyson; Sarah V Harding; Siew Hoon Sim; Hui Hoon Chua; Chi Ho Lin; Xu Han; R Krishna M Karuturi; Ken Sung; Kun Yu; Wei Chen; Timothy P Atkins; Richard W Titball; Patrick Tan
Journal:  J Bacteriol       Date:  2006-09-22       Impact factor: 3.490

Review 8.  Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.

Authors:  Sara K Bondi; Joanna B Goldberg
Journal:  Expert Rev Vaccines       Date:  2008-11       Impact factor: 5.217

9.  Continuing evolution of Burkholderia mallei through genome reduction and large-scale rearrangements.

Authors:  Liliana Losada; Catherine M Ronning; David DeShazer; Donald Woods; Natalie Fedorova; H Stanley Kim; Svetlana A Shabalina; Talima R Pearson; Lauren Brinkac; Patrick Tan; Tannistha Nandi; Jonathan Crabtree; Jonathan Badger; Steve Beckstrom-Sternberg; Muhammad Saqib; Steven E Schutzer; Paul Keim; William C Nierman
Journal:  Genome Biol Evol       Date:  2010-01-22       Impact factor: 3.416

10.  Protection against experimental melioidosis following immunization with live Burkholderia thailandensis expressing a manno-heptose capsule.

Authors:  Andrew E Scott; Thomas R Laws; Riccardo V D'Elia; Margaret G M Stokes; Tannistha Nandi; E Diane Williamson; Patrick Tan; Joann L Prior; Timothy P Atkins
Journal:  Clin Vaccine Immunol       Date:  2013-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.